Rechercher | Socid Friendly

Yashodhan Alandkar Ajout d’un nouvel article Health
2026-04-30 11:17:07

Precision Oncology Drug Portfolio market Forecast: Trends, Demand & Revenue Analysis
"Precision Oncology Drug Portfolio Market Summary: According to the latest report published by Data Bridge Market Research, the Precision Oncology Drug Portfolio Market The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the...

0 Commentaires 0 Parts 1142 Vue

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra

Ajout d’un nouvel article Autre
2026-04-22 10:24:52

Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034
According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...

0 Commentaires 0 Parts 3510 Vue

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra

Ajout d’un nouvel article Autre
2026-04-18 10:04:55

Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034
According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...

0 Commentaires 0 Parts 2944 Vue

Connectez-vous pour aimer, partager et commenter!
Jessica Pineda

Ajout d’un nouvel article Autre
2026-03-27 12:33:40

Global Generic Oncology Drugs Market by 2031 – Growth Drivers, Trends, and Competitive Landscape
The global Generic Oncology Drugs Market is witnessing steady expansion as healthcare systems worldwide prioritize cost-effective cancer treatment solutions. Generic oncology drugs, which are bioequivalent alternatives to branded cancer therapies, play a critical role in improving treatment accessibility and reducing healthcare expenditure. The increasing burden of cancer and the need for...

0 Commentaires 0 Parts 1598 Vue

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra

Ajout d’un nouvel article Autre
2026-04-20 11:20:27

Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034
According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...

0 Commentaires 0 Parts 3221 Vue

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra

Ajout d’un nouvel article Autre
2026-07-18 08:16:36

Global Nimustine Hydrochloride Market Growing at 3.6% CAGR Through 2034
According to a new report from Intel Market Research, the global Nimustine Hydrochloride market was valued at USD 78.5 million in 2024 and is projected to grow from USD 82.4 million in 2025 to USD 112.9 million by 2034, exhibiting a robust CAGR of 3.6% during the forecast period. Market growth is driven by increasing cancer prevalence, particularly in neurology and hematology applications,...

0 Commentaires 0 Parts 673 Vue

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra

Ajout d’un nouvel article Autre
2026-04-13 12:28:25

Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034
According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...

0 Commentaires 0 Parts 3658 Vue

Connectez-vous pour aimer, partager et commenter!
Saviiii Ssddd Ajout d’un nouvel article Health
2026-04-20 09:40:30

Testicular Cancer Drugs Market Growth, Oncology Drug Development and Targeted Therapy Trends Forecast to 2033
Introduction The testicular cancer drugs market is a crucial segment of the global oncology therapeutics industry, driven by advancements in cancer treatment and increasing awareness of early diagnosis. Testicular cancer, although relatively rare compared to other cancers, is one of the most common cancers among young men, particularly those between the ages of 15 and 35. The growing focus on...

0 Commentaires 0 Parts 1552 Vue

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra

Ajout d’un nouvel article Autre
2026-04-22 10:36:46

TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034
According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...

0 Commentaires 0 Parts 2894 Vue

Connectez-vous pour aimer, partager et commenter!